Ranitidine
Product Images NDC 53217-343

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Ranitidine (NDC 53217-343). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aidarex Pharmaceuticals Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

10 (Ranitidine 150mg 1)

10 (Ranitidine 150mg 1)
Chemical structure of ranitidine hydrochloride showing the molecular arrangement of atoms including sulfur, nitrogen, oxygen, and carbon components forming the ranitidine molecule with an HCl molecule indicated separately.*
FDA Label Image

53217-0343_ranitidine_150mg (Ranitidine 150mg 2)

53217-0343_ranitidine_150mg (Ranitidine 150mg 2)
Ranitidine USP 150mg film-coated tablets packaging label, showing a box containing 60 tablets. The label includes active ingredient details listing ranitidine hydrochloride 167.4mg equivalent to ranitidine 150mg, and mentions a round orange tablet with "IP 253" on one side. The product is labeled as a generic of Zantac and is packaged by Aidarex Pharmaceuticals LLC, with manufacturing credited to Amneal Pharmaceuticals Pvt Ltd, India. The NDC 53217-0343-60 is displayed along with lot and prescription information.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.